Truist Financial
BIIB icon

Truist Financial’s Biogen BIIB Stock Holding History

Truist Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.73M Buy
12,621
+1,055
+9% +$202K ﹤0.01% 1210
2026
Q1 		$2.12M Buy
11,566
+159
+1% +$29.3K ﹤0.01% 1288
2025
Q4 		$2.01M Buy
11,407
+2,450
+27% +$400K ﹤0.01% 1282
2025
Q3 		$1.25M Buy
8,957
+254
+3% +$34.3K ﹤0.01% 1565
2025
Q2 		$1.09M Sell
8,703
-99
-1% -$12.3K ﹤0.01% 1560
2025
Q1 		$1.2M Sell
8,802
-871
-9% -$125K ﹤0.01% 1443
2024
Q4 		$1.48M Sell
9,673
-27,073
-74% -$4.57M ﹤0.01% 1377
2024
Q3 		$7.12M Sell
36,746
-2,923
-7% -$612K 0.01% 700
2024
Q2 		$9.2M Sell
39,669
-2,753
-6% -$598K 0.01% 630
2024
Q1 		$9.15M Buy
42,422
+507
+1% +$119K 0.01% 653
2023
Q4 		$10.8M Sell
41,915
-9,681
-19% -$2.38M 0.02% 578
2023
Q3 		$13.3M Sell
51,596
-17,656
-25% -$4.72M 0.02% 503
2023
Q2 		$19.7M Sell
69,252
-1,927
-3% -$574K 0.03% 384
2023
Q1 		$19.8M Buy
71,179
+11,605
+19% +$3.21M 0.03% 380
2022
Q4 		$16.5M Sell
59,574
-7,422
-11% -$2.1M 0.03% 421
2022
Q3 		$17.9M Buy
66,996
+12,887
+24% +$2.74M 0.03% 387
2022
Q2 		$11M Sell
54,109
-9,760
-15% -$2M 0.02% 543
2022
Q1 		$13.5M Buy
63,869
+6,105
+11% +$1.33M 0.02% 546
2021
Q4 		$13.9M Sell
57,764
-24,467
-30% -$6.29M 0.02% 537
2021
Q3 		$23.3M Sell
82,231
-255
-0.3% -$83.6K 0.04% 371
2021
Q2 		$28.6M Buy
82,486
+1,216
+1% +$368K 0.05% 345
2021
Q1 		$22.7M Buy
81,270
+13,914
+21% +$3.75M 0.04% 380
2020
Q4 		$16.5M Sell
67,356
-8,220
-11% -$2.12M 0.03% 449
2020
Q3 		$21.4M Sell
75,576
-38,407
-34% -$10.7M 0.05% 334
2020
Q2 		$30.5M Buy
113,983
+13,380
+13% +$4.02M 0.07% 264
2020
Q1 		$31.8M Buy
100,603
+6,806
+7% +$2.07M 0.08% 241
2019
Q4 		$27.8M Buy
93,797
+71,395
+319% +$19.8M 0.06% 331
2019
Q3 		$5.22M Sell
22,402
-278
-1% -$64.7K 0.09% 224
2019
Q2 		$5.3M Sell
22,680
-278
-1% -$64.2K 0.09% 216
2019
Q1 		$5.43M Buy
22,958
+1,358
+6% +$428K 0.1% 211
2018
Q4 		$6.5M Buy
21,600
+19,615
+988% +$6.26M 0.13% 166
2018
Q3 		$701K Buy
1,985
+285
+17% +$98.1K 0.01% 530
2018
Q2 		$493K Sell
1,700
-64
-4% -$18K 0.01% 579
2018
Q1 		$483K Sell
1,764
-74
-4% -$23K 0.01% 583
2017
Q4 		$586K Sell
1,838
-143
-7% -$45.9K 0.01% 556
2017
Q3 		$620K Sell
1,981
-421
-18% -$125K 0.01% 542
2017
Q2 		$652K Sell
2,402
-1,090
-31% -$288K 0.01% 529
2017
Q1 		$954K Sell
3,492
-2,158
-38% -$610K 0.02% 479
2016
Q4 		$1.6M Sell
5,650
-250
-4% -$74.1K 0.03% 393
2016
Q3 		$1.85M Sell
5,900
-67
-1% -$19.8K 0.04% 376
2016
Q2 		$1.44M Buy
5,967
+38
+0.6% +$10K 0.03% 417
2016
Q1 		$1.54M Sell
5,929
-302
-5% -$79.8K 0.04% 357
2015
Q4 		$1.91M Sell
6,231
-1,190
-16% -$342K 0.05% 321
2015
Q3 		$2.17M Buy
7,421
+281
+4% +$92.8K 0.06% 303
2015
Q2 		$2.88M Buy
7,140
+2,035
+40% +$817K 0.08% 249
2015
Q1 		$2.16M Buy
5,105
+766
+18% +$302K 0.06% 275
2014
Q4 		$1.47M Buy
4,339
+96
+2% +$31.1K 0.04% 325
2014
Q3 		$1.4M Sell
4,243
-121
-3% -$39.9K 0.04% 322
2014
Q2 		$1.38M Sell
4,364
-21
-0.5% -$6.32K 0.04% 333
2014
Q1 		$1.34M Buy
4,385
+382
+10% +$121K 0.04% 323
2013
Q4 		$1.12M Buy
4,003
+218
+6% +$56.4K 0.04% 352
2013
Q3 		$911K Sell
3,785
-75
-2% -$16.8K 0.03% 357
2013
Q2 		$830K Buy
+3,860
New +$825K 0.03% 351

Other funds holding BIIB

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Truist Financial's BIIB Position: Q2 2026 in Review

Truist Financial increased its Biogen (BIIB) stake by 9.1% in Q2 2026, buying an estimated $202K and bringing the position to 12,621 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1210.

Truist Financial first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $31.8M in Q1 2020. 405 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Truist Financial held 12,621 shares of Biogen worth $2.73M as of Q2 2026.
  • Truist Financial bought 1,055 Biogen shares in Q2 2026, an estimated $202K.
  • Biogen made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1210 holding.
  • Truist Financial first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
  • Truist Financial's Biogen position peaked at $31.8M in Q1 2020.
  • 405 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.